A

Aerovate Therapeutics
D

AVTE

2.38000
USD
-0.01
(-0.42%)
مغلق
حجم التداول
1,818
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
68,984,345
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Aerovate Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powderinhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.